AtriCure, Inc. — Form 10-Q
Filed July 27, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 8/100
What the filing says
Michael H. Carrel (CEO) and Angela L. Wirick (CFO) certified the Form 10-Q for the quarter ended June 30, 2026, filed July 27, 2026. Both officers certify the financial statements fairly present the company's financial condition and results of operations, and confirm disclosure controls and internal control over financial reporting are effective with no material weaknesses or fraud involving management disclosed.
Why this rating
Routine Sarbanes-Oxley certification with no adverse findings; standard quarterly filing requirement, immaterial to business trajectory.
See more from July 27, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.